Article info
Abstract
Posters October 6
COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY
Citation
COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY
Online issue publication
December 03, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2004 IGCS